Sowell Financial Services’s Direxion Daily S&P Biotech Bear 3X ETF LABD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-264
Closed -$67K 1722
2021
Q1
$67K Buy
+264
New +$51.2K ﹤0.01% 1535
2020
Q3
Sell
-3
Closed -$2K 2631
2020
Q2
$2K Hold
3
﹤0.01% 2168
2020
Q1
$9K Buy
+3
New +$8.56K ﹤0.01% 1635

Other funds holding LABD

Sowell Financial Services's LABD Position: Q2 2021 in Review

Sowell Financial Services sold out of Direxion Daily S&P Biotech Bear 3X ETF (LABD) in Q2 2021, closing a stake of 264 shares — an estimated $67K sold.

Sowell Financial Services first reported a position in LABD in Q1 2020 and held it in 3 quarters. The position peaked at $67K in Q1 2021. 18 funds tracked by Wall St. Rank hold LABD as of Q2 2021.

  • Sowell Financial Services reported no remaining Direxion Daily S&P Biotech Bear 3X ETF position as of Q2 2021 after selling out during the quarter.
  • Sowell Financial Services sold 264 Direxion Daily S&P Biotech Bear 3X ETF shares in Q2 2021, an estimated $67K.
  • Sowell Financial Services first reported a position in Direxion Daily S&P Biotech Bear 3X ETF in Q1 2020 and held it in 3 quarters.
  • Sowell Financial Services's Direxion Daily S&P Biotech Bear 3X ETF position peaked at $67K in Q1 2021.
  • 18 funds tracked by Wall St. Rank held Direxion Daily S&P Biotech Bear 3X ETF as of Q2 2021.

Based on Sowell Financial Services's 13F filing for Q2 2021, filed 5 Aug 2021.